Elbus Tablet

Adult dose

Typically, take 2 tablets orally twice a day, morning and before bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice a day or 4 tablets once a day before bedtime. Especially for duodenal ulcer patients, taking 4 tablets twice a day in the morning and before bedtime achieves higher therapeutic rates. For ulcers caused by the use of NSAIDs or in combination therapy to prevent gastric and duodenal ulcers during long-term NSAID use, the doses remain the same. Generally, diseases caused by NSAID use heal within 8 weeks, but depending on the patient, healing periods may extend. For patients with recurrent ulcers who have shown exceptional efficacy with this drug's short-term therapy, maintenance therapy is 2 tablets once daily before bedtime. 2) Gastroesophageal reflux disease For 8 weeks, administer 2 tablets twice a day or 4 tablets once daily before bed. For severe gastroesophageal reflux disease patients, the dose may be increased to 4 tablets four times a day. 3) Zollinger-Ellison syndrome As an initial dosage, begin treatment with 2 tablets three times a day and may increase as needed. In cases of severe disease, doctors may prescribe a total of 6 g of ranitidine daily. 4) Peptic ulcer, acute stress ulcers, and upper gastrointestinal bleeding due to acute mucosal lesions When oral administration is possible, transition from injection to oral administration, taking 2 tablets twice a day. 5) Pre-anesthesia dosing (to prevent Mendelson's syndrome) Administer 2 tablets 2 hours before anesthesia induction. Ideally, take 2 tablets the night before surgery as well.

This medication should not be administered to patients undergoing dialysis or those with allergies to this drug or its ingredients. Patients with a history of acute porphyria should also not use this drug, nor should it be administered to patients with renal impairment, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients on a restricted potassium diet. Use with caution in patients with liver dysfunction or a history of drug allergies, the elderly, and those with a history of renal impairment. If taking NSAIDs, especially elderly patients or those with a history of peptic ulcers should undergo regular check-ups. This drug can mask symptoms of gastric cancer, so patients over middle age with gastric ulcers or new or changing dyspeptic symptoms should confirm malignancy before treatment. Helicobacter pylori-positive gastric and duodenal ulcer patients require eradication therapy. Severe patients in intensive care may develop bezoars after administration of this drug, so caution is needed, and patients with low phosphate levels may experience impaired absorption of phosphorus due to the aluminum component in this drug. Patients who have difficulty swallowing should be cautious as this drug may lead to respiratory complications after ingestion. This drug can rarely cause severe allergic reactions or shock; if unusual symptoms occur during administration, it should be discontinued immediately, and healthcare professionals should be consulted. Symptoms of hypersensitivity such as skin rash, urticaria, angioedema, fever, and respiratory distress may occur, and use should be stopped if such symptoms arise. Blood tests may show decreases in white blood cells and platelets or liver function abnormalities, and if symptoms appear, immediate consultation with a physician is advised. Abnormalities in heart rhythm, gastrointestinal symptoms, dizziness, drowsiness, mental confusion, headaches, and other neurological symptoms may also occur rarely necessitating caution. Long-term use should be avoided, and during treatment, symptoms along with blood, liver, and kidney functions should be periodically monitored. Elderly patients or those with chronic lung diseases or diabetes may have a higher risk of developing pneumonia while using this drug. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating hazardous machinery. This drug may interact with other medications, so if other drugs are being taken, it is essential to inform healthcare professionals. Especially when used in conjunction with anticoagulants or certain antibiotics and anticonvulsants, dose adjustment may be necessary. Pregnant or breastfeeding women are advised against using this medication. Safety in children has not been fully established, so its use is not recommended. This drug may affect some clinical test results, so inform healthcare professionals about its use during testing. In the event of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and blood dialysis may be required for removal if necessary. This drug reduces gastric acid secretion, which may lead to an increase in bacterial growth in the gastrointestinal tract, so regular check-ups including eye examinations are necessary during prolonged use.

Serious side effects

Urticaria, severe swelling (including angioedema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress with cough and fever, yellowing of the skin or eyes (jaundice), extreme malaise, sudden and severe headaches, thunderclap headaches, seizures, confusion, visual disturbances.

Mild side effects

• Skin rash
• urticaria
• angioedema
• fever
• bronchospasm
• hypotension
• chest pain
• neutropenia
• reversible leukopenia
• thrombocytopenia

Store this medication in a sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the drug's efficacy and prevent degradation.

Appearance

White round film-coated tablet

Package unit

500 tablets/bottle, 30 tablets/bottle